Pharmafile Logo
Pharmafocus logo
Advanced Search

transparency

Showing 15 posts of 93 posts found.

HRA must continue ‘progress towards clinical trial transparency’

August 19, 2015
Research and Development EMIG, Ethical Medicines Industry Group, Richmond Pharmacology, clinical trial registration, clinical trial transparency, health research authority, hra, sense about science, transparency

Campaigners and industry leaders have urged the Health Research Authority to ensure that its work to bring about full transparency …

News
Scales of justice

Judge rules pharma has ‘ethical’ transparency obligation – reaction

July 29, 2015
Research and Development Ben Goldacre, Richmond Pharmacology, alltrials, clinical trials, health research authority, hra, sense about science, transparency

Both sides of a bitterly contested legal battle over a major part of the industry’s transparency drive have reacted to …

News
Gavel

Judge backs HRA in transparency legal case

July 28, 2015
Research and Development EU Clinical Trial Regulation, Richmond Pharmacology, alltrials, clinical trial regulation, clinical trials, health research authority, sense about science, transparency

A judge has ruled that there are likely to be no legal grounds to block the Health Research Authority’s plans …

News
Sense About Science

Ruling in transparency case ‘due within days’

July 17, 2015
Research and Development EMIG, EU Clinical Trial Regulation, Ethical Medicines Industry Group, Richmond Pharmacology, alltrials, clinical trials, health research authority, hra, sense about science, transparency

A judge is set to rule on a controversial legal challenge to the requirement for the pharma industry to register …

News

It’s time the industry spoke out about legal challenge to clinical trial transparency

July 16, 2015
Research and Development Richmond Pharmacology, alltrials, clinical trials, health research authority, hra, judicial review, legal challenge, sense about science, transparency

The judicial review brought by Richmond Pharmacology against the Health Research Authority – erroneous, a waste of public money and …

Feature

Industry awaits outcome of transparency legal challenge

July 16, 2015
Research and Development Richmond Pharmacology, alltrials, clinical trials, health research authority, hra, judicial review, legal challenge, sense about science, transparency

A judge will today hear arguments from the Health Research Authority and campaigners who are contesting a judicial review of …

News

Pharma firm seeks judicial review against transparency

May 21, 2015
Medical Communications, Research and Development, Sales and Marketing Richmond Pharmacology, hra, transparency

The battle for greater transparency in the pharma industry is to take another twist after a company lodged a legal …

News

World Health Organisation calls for full trial transparency

April 14, 2015
Research and Development, Sales and Marketing Ben Goldacre, EU, WHO, World Health Organisation, alltrials, clinical trials, sense about science, transparency

The World Health Organization has thrown its weight behind clinical trial transparency in a new statement on its position. WHO …

News

WHO: New measures needed to reduce high drug costs

March 26, 2015
Research and Development, Sales and Marketing Europe, WHO, pricing, transparency, world health organization

New approaches to drug pricing and reimbursement are needed to make sure pharma provides access to new medicines, according to …

News
Pharma image

Pharma’s reputation ‘is worsening among patients’

February 10, 2015
Medical Communications, Research and Development, Sales and Marketing HIV, ViiV Healthcare, patientview, pharma, reputation, transparency

Only around four in ten patients believe pharma has a good reputation and many companies are failing to win patient …

News
Tamiflu image

Government spending on Tamfilu is justified

January 30, 2015
Research and Development, Sales and Marketing BMJ, Lancet, Roche, Tamiflu, alltrials, oseltamivir, transparency

The most thorough analysis of Roche’s Tamiflu to date suggests that the controversial treatment can shorten the duration of flu …

News
EMA image

EMA launches consultation on clinical trials

January 22, 2015
Research and Development, Sales and Marketing EFPIA, EMA, EU, Europe, Goldacre, alltrials, transparency

The European Medicines Agency has invited pharma to comment on its proposals to ramp up transparency in the industry and …

News
data report

Sharing trial data should be ‘expected norm’ says US think-tank

January 15, 2015
Medical Communications, Research and Development, Sales and Marketing FDA, Goldacre, Institute of Medicine, clinical trials, transparency

Clinical trial data is in the public interest and should be shared no less than 30 days following regulatory approval …

News
Publishing image

Medical publishing: can we rely on it?

January 5, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, csr, journals, medical publishing, peer, publishing, transparency

The explosive proliferation of journals suggests that medical publishing is an attractive business. But it’s not without its critics, as …

Feature
People image

The valuable world of Real World Evidence

December 8, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing clinical trials, data, martin goldman, real world evidence, transparency

What do you believe? Are you a doubting Thomas, always wanting to have the pragmatic proof personally presented to you, …

Feature

Latest content

FDA accepts new drug application for Orexo’s opioid overdose medication

November 28, 2023

Arcturus Therapeutics gains FDA ODD for cystic fibrosis treatment

November 28, 2023

Sanofi and Regeneron share results from phase 3 trial for Dupixent as COPD treatment

November 27, 2023

GSK shares results from phase 3 trial for Blenrep as multiple myeloma treatment

November 27, 2023

Alladapt Immunotherapeutics gains FDA Fast Track Designation for ADP101 as food allergy treatment

November 24, 2023